Plerixafor injection is a hematopoietic stem cell mobilizer used in combination with granulocyte-colony stimulating factor in patients with non-Hodgkin's lymphoma or multiple myeloma.
Pharmacy legislation covering important issues, such as PBM reform and scope of practice, is gaining momentum at the state and federal levels. Here are the ones to watch.